The Anteis policy is twofold: developing viscoelastic products (OVD) adapted to different eye surgery programs and designing devices capable of treating major pathologies of the eye's anterior segment.
Thanks to its excellent knowledge of ophthalmology, the Anteis team has created product ranges that perfectly fulfil surgeons’ requirements and respect the constraints of surgical programs.
Vision of the future
“Favouring the patients’ visual performance and the surgeons’ comfort thanks to solutions that are effective and easy to use” is the work focus for all upcoming projects.The R&D team is already working on several areas to form the basis of new projects.
What could be more logical? Because in ophthalmology, as well as orthopaedics and aesthetic dermatology, Anteis clearly displays its ambition: becoming one of the most innovative companies in its field.
The product ranges
Anteis currently proposes no less than three viscoelastic gel families:Ophteis range - animal origin
Ophteisbio range - non animal origin
Methylvisc range - HPMC
In the beginning of next year, Anteis will launch a drainage viscoelsatic injectable implant, presented in a glass syringe, indicated as an adjuvant during perforating and non-perforating glaucoma surgery.
recommendprint this page top
